» Articles » PMID: 39337487

Immunogenetic Landscape in Pediatric Common Variable Immunodeficiency

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Sep 28
PMID 39337487
Authors
Affiliations
Soon will be listed here.
Abstract

Common variable immunodeficiency (CVID) is the most common symptomatic antibody deficiency, characterized by heterogeneous genetic, immunological, and clinical phenotypes. It is no longer conceived as a sole disease but as an umbrella diagnosis comprising a spectrum of clinical conditions, with defects in antibody biosynthesis as their common denominator and complex pathways determining B and T cell developmental impairments due to genetic defects of many receptors and ligands, activating and co-stimulatory molecules, and intracellular signaling molecules. Consequently, these genetic variants may affect crucial immunological processes of antigen presentation, antibody class switch recombination, antibody affinity maturation, and somatic hypermutation. While infections are the most common features of pediatric CVID, variants in genes linked to antibody production defects play a role in pathomechanisms of immune dysregulation with autoimmunity, allergy, and lymphoproliferation reflecting the diversity of the immunogenetic underpinnings of CVID. Herein, we have reviewed the aspects of genetics in CVID, including the monogenic, digenic, and polygenic models of inheritance exemplified by a spectrum of genes relevant to CVID pathophysiology. We have also briefly discussed the epigenetic mechanisms associated with micro RNA, DNA methylation, chromatin reorganization, and histone protein modification processes as background for CVID development.

References
1.
Martinez-Cano J, Campos-Sanchez E, Cobaleda C . Epigenetic Priming in Immunodeficiencies. Front Cell Dev Biol. 2019; 7:125. PMC: 6635466. DOI: 10.3389/fcell.2019.00125. View

2.
Rao D, OConnell R, Chaudhuri A, Garcia-Flores Y, Geiger T, Baltimore D . MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity. 2010; 33(1):48-59. PMC: 2911227. DOI: 10.1016/j.immuni.2010.06.013. View

3.
Mensa-Vilaro A, Bravo Garcia-Morato M, Calle-Martin O, Franco-Jarava C, Martinez-Saavedra M, Gonzalez-Granado L . Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases. J Allergy Clin Immunol. 2018; 143(1):359-368. DOI: 10.1016/j.jaci.2018.09.009. View

4.
Camacho-Ordonez N, Ballestar E, Timmers H, Grimbacher B . What can clinical immunology learn from inborn errors of epigenetic regulators?. J Allergy Clin Immunol. 2021; 147(5):1602-1618. DOI: 10.1016/j.jaci.2021.01.035. View

5.
Materna-Kiryluk A, Pollak A, Gawalski K, Szczawinska-Poplonyk A, Rydzynska Z, Sosnowska A . Mosaic IL6ST variant inducing constitutive GP130 cytokine receptor signaling as a cause of neonatal onset immunodeficiency with autoinflammation and dysmorphy. Hum Mol Genet. 2021; 30(3-4):226-233. DOI: 10.1093/hmg/ddab035. View